Small Bone and Joint Devices Market Size, Share & Trends Analysis - United States - 2024-2030 - MedSuite - Includes: Shoulder Reconstruction Devices, Elbow Repair Devices, and 2 more
In 2023, the U.S. market for small bone and joint orthopedic devices was estimated to be worth over $3.3 billion. Over the forecast period, the market is anticipated to grow at a compound annual growth rate (CAGR) of 6.0%, reaching nearly $5 billion.
The comprehensive report on this market covers various segments, including shoulder reconstruction, elbow repair, hand and wrist, and foot and ankle devices. Each anatomical area is further broken down by device type, ranging from total joint reconstruction to internal fixation and bone fusion.
Included in the Market Report:Unit Sales, Average Selling Prices, Market Valuation & Growth Trends
10-Year Forecast Period
Segment-Specific Market Drivers & Limiters
Competitive Landscape with Market Shares
Overview of Recent Mergers & Acquisitions
Disease Trends & Demographic Data
Detailed Competitor Profiles, Product Offerings, and SWOT Analyses
Trends in the U.S. Small Bone and Joint Device Market The market is seeing a shift toward digital innovations such as robotic surgery, digital technology, and data analytics aimed at enhancing patient outcomes. For instance, the use of 3D-printing technology is gaining traction, as it provides customized orthopedic solutions tailored to the unique anatomical needs of each patient. This technology is expected to reduce manufacturing costs for custom implants while offering greater precision in implant placement during surgeries.
Market Share Insights In 2023, Stryker, Arthrex, and DePuy Synthes dominated the U.S. small bone and joint orthopedic device market, holding over 50% of the market share in extremity reconstruction and fixation. Stryker and Arthrex lead the joint reconstruction segment, while DePuy Synthes focuses on internal fixation. The shoulder and foot/ankle segments remain key areas of market dominance. Other notable companies in specialized niches include Aptis Medical, Arthrex, restor3d, and Stryker, each leading specific areas such as ulnar head replacement, syndesmotic repair, talus replacement, and ankle replacement, respectively. The entrance of new players is expected, supported by FDA approvals and increased investment. For example, Treace Medical introduced the Lapiplasty® system for bunion correction, while Anika Therapeutics expanded into joint preservation through acquisitions. Paragon 28 also expanded its talus replacement offerings by acquiring Additive Orthopaedics.
Market Segmentation Overview:Shoulder Reconstruction Devices: Covering anatomic, reversed, hemi, resurfacing, and revision shoulder implants, along with internal fixation plates and screws.
Elbow Repair Devices: Includes primary elbow and radial head implants, as well as internal fixation devices.
Foot and Ankle Devices: Features primary ankle replacements, ankle fusion devices, midfoot devices, and bunion treatment solutions.
Hand and Wrist Devices: Encompasses wrist replacement, wrist fusion, ulnar head replacement, hand digit implants, and distal radius fixation plates and screws.
Report ScopeRegion: United States
Base Year: 2023
Forecast Period: 2024–2030
Historical Data: 2020–2022
Quantitative Analysis: Market Size, Market Shares, Forecasts, Growth Rates, Unit Sales, and Average Selling Prices
Qualitative Insights: Impact of COVID-19, Market Growth Drivers, Competitive Analysis, Mergers & Acquisitions, Technological Disruptions, Disease Insights
Data Sources: Industry Leader Interviews, Government Data, Regulatory Filings, Hospital Data, Import/Export Information